Search Within

Eli Louis Diamond

Formats
  1. Journal Article (99)
  2. Meeting Abstract (84)
  3. Research Letter (8)
  4. Review (6)
  5. Book Section (4)
  6. Guidelines (3)
  7. Correspondence (2)
  8. Editorial (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (104)
  2. Tow Center for Developmental Oncology (TCDO) (97)
  3. GSK Faculty (91)
  4. Center for Hematologic Malignancies (80)
  5. Hematologic Malignancies, Division of (79)
  6. Executive Committee, Center for Hematologic Malignancies (72)

More Groups

People
  1. Omar Abdel-Wahab (72)
  2. Benjamin Durham (62)
  3. David Hyman (40)
  4. Raajit Rampal (34)
  5. Anne Reiner (28)
  6. Marc Rosenblum (25)

More People

Years
  1. 2025 (14)
  2. 2024 (16)
  3. 2023 (28)
  4. 2022 (18)
  5. 2021 (10)
  6. 2020 (15)

More Years

Publications
  1. Blood (31)
  2. Neuro-Oncology (23)
  3. Pediatric Blood and Cancer (21)
  4. Journal of Clinical Oncology (12)
  5. Blood Advances (10)
  6. Psycho-Oncology (6)

More Publications

Publishers
  1. American Society of Hematology (41)
  2. Oxford University Press (31)
  3. Wiley Periodicals, Inc (21)
  4. American Society of Clinical Oncology (12)
  5. Nature Publishing Group (10)
  6. American Association for Cancer Research (9)

More Publishers

Results (208)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathologic features of Erdheim-Chester disease (ECD): A histiocytic neoplasm characterized by deregulation of RAS/RAF/MEK/ERK pathway
    Meeting Abstract

    Ozkaya, N.; Durham, B. H.; Park, C.; Rosenblum, M.; Diamond, E.; Dogan, A.
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • Rates and risks for late referral to hospice in patients with primary malignant brain tumors
    Journal Article

    Diamond, E. L.; Russell, D.; Kryza-Lacombe, M.; Bowles, K. H.; Applebaum, A. J.; Dennis, J.; Deangelis, L. M.; Prigerson, H. G.
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Clinicopathologic features of Erdheim-Chester disease (ECD): A histiocytic neoplasm characterized by deregulation of RAS/RAF/MEK/ERK pathway
    Meeting Abstract

    Ozkaya, N.; Durham, B. H.; Park, C.; Rosenblum, M.; Diamond, E.; Dogan, A.
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Diverse and targetable kinase alterations drive histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Diamond, E. L.; Haroche, J.; Yao, Z.; Ma, J.; Parikh, S. A.; Choi, J.; Kim, E.; Cohen-Aubart, F.; Lee, S. C. W.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Diverse and targetable kinase alterations drive histiocytic neoplasms
    Journal Article

    Diamond, E. L.; Durham, B. H.; Haroche, J.; Yao, Z.; Ma, J.; Parikh, S. A.; Wang, Z.; Choi, J.; Kim, E.; Cohen-Aubart, F.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • Diverse kinase mutations and fusions drive non-Langerhans cell histiocytoses
    Meeting Abstract

    Durham, B.; Diamond, E.; Yao, Z.; Ma, J.; Choi, J.; Kim, E.; Lee, S.; Gao, Y.; Micol, J. B.; Campbell, P.; more...
    Pediatric Blood and Cancer (2015)

    Fulltext@MSK | Save
  • Diffuse loss of cerebral grey matter structures in Erdheim-Chester disease
    Meeting Abstract

    Diamond, E. L.; Hatzoglou, V.; Pandya, S.; Abdel-Wahab, O.; Hyman, D. M.; Rampal, R.; Raj, A.
    Pediatric Blood and Cancer (2015)

    Fulltext@MSK | Save
  • Existential distress among caregivers of patients with brain tumors: A review of the literature
    Meeting Abstract

    Applebaum, A.; Corner, G.; Kryza-Lacombe, M.; Helcer, J.; DeRosa, A.; Diamond, E.
    Psycho-Oncology (2015)

    Fulltext@MSK | Save
  • Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Thomas, A. A.; Beal, K.; McNeill, K. A.; Kaley, T. J.; Deangelis, L. M.; Mellinghoff, I. K.; Diamond, E. L.; Chan, T. A. T.; Young, R. J.; Perez, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations
    Journal Article

    Hyman, D. M.; Puzanov, I.; Subbiah, V.; Faris, J. E.; Chau, I.; Blay, J. Y.; Wolf, J.; Raje, N. S.; Diamond, E. L.; Hollebecque, A.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save